Benitec Biopharma (BNTC) Non Operating Income (2019 - 2025)

Benitec Biopharma has disclosed Non Operating Income across 7 years of filings, most recently posting $19000.0 for Q4 2025.

• Non Operating Income for Q4 2025 came in at $19000.0, down 98.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $731000.0 (down 29.37% YoY), and the FY2025 annual result was -$131000.0, up 35.78% from the prior year.
• Non Operating Income came in at $19000.0 for Q4 2025 at Benitec Biopharma, down from $838000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $1.3 million in Q4 2024 to a low of -$513000.0 in Q3 2022.
• The 5-year median for Non Operating Income is -$56000.0 (2023), against an average of $25789.5.
• Across the five-year window, Non Operating Income sank 1438.1% in 2021 and jumped 7931.25% in 2024, its largest moves.
• Benitec Biopharma's Non Operating Income stood at $14000.0 in 2021, then surged by 1321.43% to $199000.0 in 2022, then plunged by 108.04% to -$16000.0 in 2023, then surged by 7931.25% to $1.3 million in 2024, then slumped by 98.48% to $19000.0 in 2025.
• The last three Non Operating Income figures came in at $19000.0 (Q4 2025), $838000.0 (Q3 2025), and -$126000.0 (Q2 2025), per Business Quant data.